Centre for the AIDS Programme of Research in South Africa

Recent papers from Centre for the AIDS Programme of Research in South Africa

1. Extended in vivo activity of VRC01 HIV-1 prophylaxis entails initial protective efficacy and subsequent breakthrough infectionsScience Translational Medicine · 2026
2. Pharmacogenomics in Cancer Treatment: Challenges and Opportunities in African SettingsCancer Medicine · 2026
3. High burden of sexually transmitted infections and low treatment uptake among adolescent girls and young women in Ugandan fishing communities: a cross-sectional studyBMC Infectious Diseases · 2026
4. The Performance of Genotypic Profiling and Distribution of Minimum Inhibitory Concentrations in Bedaquiline-Resistant TuberculosisAntibiotics · 2026
5. Time to Stop Using Ineffective Covid-19 DrugsNew England Journal of Medicine · 2022
6. Long-Acting HIV Therapy in African Adults with Adherence ChallengesNew England Journal of Medicine · 2026
7. A multiplex real-time PCR subtyping assay combining chromosomal ( pmpH ) and plasmid ( pgp3 ) markers for differentiation of LGV and non-LGV Chlamydia trachomatisMicrobiology Spectrum · 2026
8. Mental Health Outcomes Among Transgender People in South Africa During the COVID-19 Pandemic: A Cross-Sectional Analysis of Service Disruptions and Social, Structural, and Relational CorrelatesLGBT Health · 2026
9. An exploration of multilevel factors influencing the uptake of strengthened integrated depression care as part of routine primary health care services in KwaZulu-Natal, South AfricaInternational Journal of Mental Health Systems · 2026
10. HIV viral suppression in children and adolescents who transitioned from ritonavir‐boosted lopinavir‐ to dolutegravir‐based antiretroviral therapy in LesothoHIV Medicine · 2026
11. Recent insights from prophylactic passive immunization trials of HIV-1 broadly neutralizing antibodies: implications for vaccine designCurrent Opinion in HIV and AIDS · 2026
12. Equitable Access to GLP-1 Receptor Agonists—Essential but Not AccessibleJAMA · 2026
13. Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trialsNature Microbiology · 2026
14. Pharmacokinetics and safety of dolutegravir in term neonates exposed to HIV-1 (IMPAACT 2023): a phase 1, open-label, multicentre studyThe Lancet HIV · 2026
15. How the multiple burdens of daily oral antiretroviral therapy shape the acceptability of long-acting injectable cabotegravir and rilpivirine among people living with HIV in Uganda and South Africa: a sub-study of the IMPALA trialAIDS Care · 2026
16. Hypertension knowledge, self-management barriers, and provider counseling among women living with HIV and hypertension in KwaZulu-Natal, South Africa: a cross-sectional studyAIDS Research and Therapy · 2026
17. Trends in advanced HIV disease, treatment interruption, and viraemia in KwaZulu-Natal, South AfricaPLOS Global Public Health · 2026
18. Understanding the Mental Health Impacts of Climate Change in South Africa: Qualitative Insights From Researchers, Practitioners, Ethicists, and Funders on the Need for a Transdisciplinary ApproachHealth Science Reports · 2026
19. HIV associated immune aging among people living with HIV: implications for long-term antiretroviral therapy and potential HIV cure interventions in sub-Saharan AfricaFrontiers in Immunology · 2026
20. Engaging tuberculosis-affected people in investment decisions: applying a people-centered design approach in Viet NamBMC Public Health · 2026